KV Pharmaceutical Company

30 September 2013

 

US $100,000,000 First Lien Secured Term Loan Facility

Law Debenture Trust Company of New York has been appointed as agent for K-V Pharmaceutical Company’s new $100 million credit facility.  K-V emerged from Chapter 11 bankruptcy on September 16.  This facility is a critical element of their $375 million recapitalization.  K-V is specialty pharmaceutical company that focuses on women’s health care products.  
Back to top